Our findings suggest that an increase, rather than decrease—as previously assumed—in levels of zinc or manganese in rare LoF carriers may drive improved β-cell performance or survival, and insulin output, lowering T2D risk. This evidence concerns the gene INS and type 2 diabetes mellitus.